insights_auto
Why is BOT down 20,00%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
0,0080 A$
arrow_downward
-20,00%(-0,0020) 1D
20 նոյ, 16:10:07 GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
0,01 A$
High
0,01 A$
Low
0,01 A$
Mkt. cap
22,10 մլն
Avg. vol.
11,07 մլն
Volume
8,60 մլն
52-wk high
0,15 A$
52-wk low
0,01 A$
EPS
-0,03 A$
Shares outstanding
2,76 մլրդ
No. of employees
11
Open
0,01 A$
High
0,01 A$
Low
0,01 A$
Mkt. cap
22,10 մլն
Avg. vol.
11,07 մլն
Volume
8,60 մլն
52-wk high
0,15 A$
52-wk low
0,01 A$
EPS
-0,03 A$
Shares outstanding
2,76 մլրդ
No. of employees
11
News stories
From web sources and news partners
Trefis
·
51 րոպե առաջ
25 S&P 500 Stocks Just Made New 52-Week Lows
Chattanooga Times Free Press
·
1 ժամ առաջ
S&P 500 sinks 3.7% and Nasdaq composite goes negative for the year as tech sell-off worsens
Traders Union
·
2 ժամ առաջ
VIX fear index hits highest level since April 2025 as S&P 500 plunges
BigGo Finance
·
3 ժամ առաջ
S&P 500 Falls for Seventh Straight Session, Enters Correction as AI Stock Rally Loses Steam
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd